We are proposing to conduct a randomized controlled trial to determine the effectiveness of various text-based and contingency management interventions on Opioid Use Disorder patients. Our goals are to measure their engagement with recovery treatment. We plan to enroll 2,000 participants into one of the following 4 arms.

Patients enrolled into the Way to Health CareConnect text line as part of usual care and meeting eligibility criteria will be enrolled in this randomized control trial and randomized to:

1.      Augmented usual care (standard Way to HealthCareConnect textline) Patients can call or text the on-call substance use navigators (SUN) from 9a-9p, 7 days a week.
2.      Augmented usual care + text-message check-ins (standard Way to Health CareConnect Textline) Patients can call or text the on-call substance use navigators (SUN) from 9a-9p, 7 days a week AND (text-message check-ins) patients will receive automated text-message check-ins up to once per day for 30 days to see if the patient needs help with anything.
3.      Augmented usual care + contingency management (standard Way to Health CareConnect Textline) and, participants will be compensated for going to their follow-up appointments. 
4.      Augmented usual care + CM + Text-message check-ins (standard Way to Health CareConnect textline) AND text-message check-inspatients will receive automated text-message check-ins up to once perday for 30 days to see if the patient needs help with anything AND, participants will receive compensation for attending their follow-up appointments. 

Patients enrolled in the trial will also be invited to complete the intake survey and follow-up surveys. Patients will receive financial compensation for completing these surveys. Those enrolled in the Contingency Management arm will receive additional financial incentives for attending their follow-up appointments. We plan to enroll 2,000 participants for this study.

The goal of this program is to determine the most effective interventions strategies for engaging patients with OUD with treatment care.

You may be eligible for this study if you meet the following criteria:

• Conditions: Medical Research
• Age: - 99 Years
• Gender: All